This laboratory guide details the precise protocols for reconstituting lyophilized Melanotan 2 (MT-2) for in vitro and preclinical research applications. Learn how to calculate solvent volumes, maintain peptide stability, and execute aseptic volumetric preparations using analytical-grade reagents.
This laboratory guide details the precise protocols for reconstituting lyophilized Melanotan 2 (MT-2) for in vitro and preclinical research applications. Learn how to calculate solvent volumes, maintain peptide stability, and execute aseptic volumetric preparations using analytical-grade reagents.
To reconstitute Melanotan 2 for laboratory research, calculate the required concentration, sanitize the vial septum with 70% isopropyl alcohol, and slowly introduce sterile Bacteriostatic Water (0.9% benzyl alcohol) along the internal glass wall using a sterile syringe. Allow the lyophilized cake to dissolve naturally without vigorous shaking to prevent mechanical shear stress and peptide denaturation.
Following total dissolution, the reconstituted solution should appear completely clear, colorless, and free of visible particulate matter. Laboratory personnel should aliquoting the working solution into single-use, low-binding polypropylene microcentrifuge tubes before storing at -20°C or -80°C for long-term experimental consistency.
Melanotan 2 (CAS 121062-08-6) is a synthetic cyclic heptapeptide analog of the naturally occurring endogenous peptide alpha-melanocyte-stimulating hormone (α-MSH). Structurally defined as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, MT-2 features a lactam bridge between the Asp and Lys residues, providing enhanced metabolic resistance against enzymatic degradation compared to native linear peptides.
In cell culture models and tissue preparations, this structural stabilization yields a significantly prolonged biological half-life and elevated receptor binding affinity. When sourced from high-purity vendors, raw Melanotan 2 10mg presents as a white, dense lyophilized powder that requires appropriate aqueous reconstitution prior to binding assays or spectroscopic analysis.
Preclinical literature demonstrates that Melanotan 2 acts as a non-selective agonist across several melanocortin receptor subtypes, including MC1R, MC3R, MC4R, and MC5R. In vitro receptor binding assays indicate that its primary historical focus has been the MC1R receptor, which is expressed on melanocytes and governs melanogenesis and skin pigmentation responses.
Beyond MC1R activation, rodent models show that central MC3R and MC4R stimulation by MT-2 plays a pivotal role in feeding behavior, metabolic rate modulation, and autonomic sexual reflex pathways. Researchers utilizing PX1 Research catalog items should consult published binding kinetics literature to account for potential multi-receptor cross-talk during cell-based assays.
Aseptic reconstitution of research compounds requires specialized laboratory equipment and sterile reagents to prevent bacterial contamination and maintain physical integrity over extended assay periods. Standard reconstitutions require analytical-grade bacteriostatic water containing 0.9% benzyl alcohol, which inhibits microbial growth during multi-use sampling.
Equipment protocols mandate the use of single-use 1 mL to 3 mL sterile syringes equipped with fine-gauge needles (27G–31G), sterile 70% isopropyl alcohol wipes, and low-protein-binding microcentrifuge tubes. For precise liquid handling, automated pipettes calibrated to ISO 8655 standards should be used alongside our dedicated peptide reconstitution calculator to verify volume accuracy.
1. Preparation & Disinfection: Place the lyophilized Melanotan 2 10mg vial and diluent on a disinfected laminar flow workbench. Swab the rubber septa of both vials with 70% isopropyl alcohol and allow them to air dry for 30 seconds. 2. Pressure Equalization & Solvent Withdrawal: Using a sterile syringe, draw up the exact volume of diluent required (e.g., 2.0 mL of bacteriostatic water). Equalize air pressure by drawing air equal to the diluent volume prior to inserting the needle into the diluent vial.
3. Solvent Transfer: Direct the needle tip toward the inner glass wall of the Melanotan 2 vial. Gently depress the plunger, allowing the diluent to trickle down the side of the glass rather than spraying directly onto the lyophilized powder cake. 4. Dissolution: Withdraw the syringe and gently swirl the vial in a circular motion. Never shake the vial vigorously, as high mechanical shear can disrupt secondary structural interactions. Allow the solution to rest at room temperature until the powder completely dissolves.
Accurate volumetric calculations are essential for repeatable dose-response curves in preclinical assays. Adding 1.0 mL of reconstituting diluent to a 10 mg vial yields a final working concentration of 10 mg/mL (10 mcg/µL). Conversely, adding 2.0 mL yields a concentration of 5 mg/mL (5 mcg/µL), allowing finer pipetting resolution for sub-microgram microplate setups.
The table below outlines common diluent volume ratios for a standard 10 mg research vial:
• 1.0 mL Diluent = 10 mg/mL (10 µg/µL) • 2.0 mL Diluent = 5 mg/mL (5 µg/µL) • 2.5 mL Diluent = 4 mg/mL (4 µg/µL) • 5.0 mL Diluent = 2 mg/mL (2 µg/µL)
For complex dilution schemes or custom concentration requirements, laboratory staff can cross-reference our research database hub to maintain standard operating procedure compliance across experimental runs.
Lyophilized Melanotan 2 remains stable at -20°C for up to 24 months when protected from light and moisture. Upon reconstitution with bacteriostatic water, aqueous MT-2 solutions retain stability for 28–30 days when maintained refrigerated at 2°C to 8°C. If reconstituted with sterile 0.9% sodium chloride without preservatives, solutions must be utilized within 24 hours.
To preserve structural stability over extended timelines, reconstitutions should be divided into single-use aliquots using low-binding polypropylene tubes and stored at -80°C. Repeated freeze-thaw cycles must be avoided, as ice crystal formation can rupture non-covalent hydrophobic interactions, leading to aggregation and loss of binding activity.
When designing comparative melanocortin receptor assays, researchers frequently evaluate MT-2 against related agonists within the same functional family. Key comparative analogs include Melanotan 1 (Afamelanotide), PT-141 (Bremelanotide), and native alpha-MSH.
While Melanotan 1 exhibits high selectivity for MC1R over other subtypes, Melanotan 2 demonstrates broader receptor binding across MC1R, MC3R, MC4R, and MC5R. PT-141—a hydroxylated metabolite derivative of MT-2—exhibits reduced MC1R activity while retaining affinity for central MC3R/MC4R pathways. Selection between these compounds depends on whether the laboratory objective targets melanogenesis or central neuro-signaling cascades.
Experimental integrity in cell culture and preclinical models requires verified research materials. Low-purity peptide batches containing truncated sequences, residual counter-ions, or heavy metals introduce uncontrollable variables that invalidate assay conclusions. Institutional buyers should require lot-specific documentation for every order.
PX1 Research ensures lot-to-lot consistency by subjecting all compounds to rigorous quality verification inside ISO 17025 accredited testing facilities. Every batch undergoes High-Performance Liquid Chromatography (RP-HPLC) for purity determination (>99%), Mass Spectrometry (ESI-MS) for mass confirmation, and chromogenic LAL assays to confirm endotoxin levels fall below standard analytical thresholds (<0.05 EU/mg). Institutions seeking volume fulfillment can review our wholesale research portal for procurement documentation.
Following standardized reconstitution protocols ensures that Melanotan 2 retains optimal biological activity across all planned analytical procedures. By utilizing proper solvents, adhering to gentle mixing procedures, avoiding thermal cycling, and verifying sample purity through analytical COAs, research teams protect their experimental models against artifacts.
For additional technical documentation, safety data sheets (SDS), or specialized sequence profiles, explore the resources available in the PX1 Research knowledge center.
What solvent is recommended for reconstituting Melanotan 2?
Bacteriostatic Water (0.9% benzyl alcohol) is recommended for multi-use laboratory sampling over a 30-day window. Sterile 0.9% Sodium Chloride or Sterile Water for Injection may be used for immediate single-use assays.
How should reconstituted Melanotan 2 be stored?
Reconstituted MT-2 solutions should be stored at 2°C to 8°C for short-term use (up to 30 days with bacteriostatic water) or aliquoted and stored at -80°C for long-term storage to prevent degradation.
Can Melanotan 2 vials be shaken to speed up dissolution?
No. Shaking reconstituted peptide solutions introduces mechanical shear stress that can cause structural denaturation or aggregation. Gentle swirling is recommended.
What is the purity standard for PX1 Research Melanotan 2?
PX1 Research provides Melanotan 2 with ≥99% purity verified via reverse-phase HPLC and mass spectrometry. Every lot includes a public Certificate of Analysis (COA) with endotoxin testing data.
What is the difference between Melanotan 1 and Melanotan 2?
Melanotan 1 (Afamelanotide) is a linear peptide with high selectivity for the MC1R receptor. Melanotan 2 is a cyclic heptapeptide with broader receptor binding affinity across MC1R, MC3R, MC4R, and MC5R.
How many mL of bacteriostatic water should be added to a 10mg MT-2 vial?
Adding 2.0 mL of solvent creates a convenient 5 mg/mL (5 mcg/µL) concentration, whereas 1.0 mL yields a 10 mg/mL (10 mcg/µL) concentration. Volume selection depends on required pipetting precision.
Is Melanotan 2 approved for human consumption or therapeutic use?
No. Melanotan 2 supplied by PX1 Research is strictly designated for laboratory research use only and is not for human or animal therapeutic, diagnostic, or clinical application.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.